Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nucleic Acids Res
2015 Aug 18;4314:7021-31. doi: 10.1093/nar/gkv652.
Show Gene links
Show Anatomy links
Human DNA ligase III bridges two DNA ends to promote specific intermolecular DNA end joining.
Kukshal V
,
Kim IK
,
Hura GL
,
Tomkinson AE
,
Tainer JA
,
Ellenberger T
.
???displayArticle.abstract???
Mammalian DNA ligase III (LigIII) functions in both nuclear and mitochondrial DNA metabolism. In the nucleus, LigIII has functional redundancy with DNA ligase I whereas LigIII is the only mitochondrial DNA ligase and is essential for the survival of cells dependent upon oxidative respiration. The unique LigIII zinc finger (ZnF) domain is not required for catalytic activity but senses DNA strand breaks and stimulates intermolecular ligation of two DNAs by an unknown mechanism. Consistent with this activity, LigIII acts in an alternative pathway of DNA double strand break repair that buttresses canonical non-homologous end joining (NHEJ) and is manifest in NHEJ-defective cancer cells, but how LigIII acts in joining intermolecular DNA ends versus nick ligation is unclear. To investigate how LigIII efficiently joins two DNAs, we developed a real-time, fluorescence-based assay of DNA bridging suitable for high-throughput screening. On a nicked duplex DNA substrate, the results reveal binding competition between the ZnF and the oligonucleotide/oligosaccharide-binding domain, one of three domains constituting the LigIII catalytic core. In contrast, these domains collaborate and are essential for formation of a DNA-bridging intermediate by adenylated LigIII that positions a pair of blunt-ended duplex DNAs for efficient and specific intermolecular ligation.
Figure 1. Tandem DNA binding surfaces of LigIII support DNA bridging. (A) The LigIIIβ protein (LigIII, 862 residues) spans four structural domains, an N-terminal zinc finger (ZnF; residues 1–100), a DNA binding domain (DBD; residues 170–390), a nucleotidyl transferase domain (NTase; residues 391–595) and the OB-fold domain (OBD; residues 596–749) that are required for efficient DNA end joining activity. Two pairs of domains, the ZnF–DBD and the NTase–OBD, comprise independent DNA binding modules (29) that are required in DNA bridging activity (cf. Figure 4B). The crystal structure of ΔZnF LigIII bound to a nicked DNA reveals a compact structure that would preclude the ZnF domain from binding to the nick (PDB 3L2P) (30). (B) We developed a time resolved FRET (TR-FRET) assay to measure intermolecular ligation of two DNAs by LigIII. In this assay, LigIII brings together DNAs labeled with Tb3+ (donor) and FITC (acceptor) to produce a FRET signal. DNA bridging activity and efficient intermolecular ligation of DNAs depend on the presence of the ZnF domain. We present evidence that this DNA bridging complex is a reaction intermediate of the intermolecular ligation pathway.
Figure 2. DNA bridging precedes intermolecular DNA ligation. (A) The real time measurement of TR-FRET (520/495 nm) signals the assembly of a DNA bridging complex, in which LigIII juxtaposes two DNAs labeled with donor and acceptor labels. Ligation reactions containing a pair of DNAs with complementary 3-nt overhangs were assembled in the absence (red) or presence (blue) of LigIII and the TR-FRET signal was monitored. The TR-FRET traces shown in Figures 2–5 are the average values of assays performed in triplicate. DNA ligation activity measured under the same reaction conditions (B) is plotted as the percentage of total DNA in the ligation product (green). (B) The time course of DNA ligation under the same reaction conditions as in (A) was monitored by running timed reaction aliquots on a 18% denaturing urea Polyacrylamide gelelectrophoresis (PAGE). DNA ligation activity is significantly slower than the TR-FRET signal, which results from the LigIII dependent juxtaposition of the labeled DNAs. The intermolecular ligation of a blunt-end DNA (Supplementary Figure S5) is markedly slower than ligation of overhanging DNA ends, suggesting that the end structure of the DNAs influences the rate-limiting step of ligation. (C) The same rapid onset of the TR-FRET signal is observed upon addition of LigIII (blue) to a pair of DNAs with 5′-OH groups that cannot be ligated, whereas the TR-FRET value remains at baseline in the absence of LigIII (red). Thus, DNA bridging complex formation is rapid and precedes DNA ligation (A). (D) PAGE analysis of the reaction with non-ligatable DNAs used in (C) shows that no ligated product is formed under conditions that produce the TR-FRET signal corresponding to DNA bridging activity.
Figure 3. Bridging requires compatible pairs of DNA ends. Pairs of non-ligatable DNAs with either complementary three nucleotide overhangs (blue) or with blunt ends (green) generated a FRET signal in the presence of LigIII, indicative of DNA bridging activity. In contrast, two mispaired combinations consisting of two DNAs with blunt and overhanging ends (orange, magenta) did not support TR-FRET and resulted in a baseline level of fluorescence.
Figure 4. Specificity of DNA bridging by LigIII. (A) The DNA binding activity of LigIII in the DNA bridging assay is effectively competed by an unlabeled DNA, saturable manner, as expected for the formation of a discrete protein–DNA complex. A pair of labeled, non-ligatable DNAs (500 nM of each) was incubated with LigIII (100 nM) in the presence of increasing concentrations of an unlabeled DNA duplex (0–8 μM). See also Supplementary Figure S2. (B) In the absence of added ATP (light blue) the TR-FRET signal amplitude is about 50% of the signal for a reaction containing ATP (100 μM; dark blue). LigIII that was completely deadenylated (orange) did not support DNA bridging and TR-FRET. (C) Addition of ATP to the deadenylated LigIII (shown in B) restored the TR-FRET signal and DNA bridging activity in a concentration-dependent manner. The TR-FRET values 30 min after addition of ATP are shown.
Figure 5. DNA bridging requires two independent DNA binding surfaces of LigIII. (A) Addition of EDTA (5 mM) abolishes the DNA bridging activity of LigIII in reaction buffer containing 5 mM MgCl2, indicating that divalent metal(s) are required for DNA binding activity. (B) Deletion mutants of LigIII lacking the ZnF (ΔZnF LigIII) or OBD (ΔOBD LigIII) domains do not form the DNA bridging complex although both mutants can bind to double-stranded DNA (Supplementary Table S1). A mixture of the ΔZnF and ΔOBD LigIII proteins also fails to bridge the labeled DNAs, consistent with a single molecule of LigIII mediating the DNA bridging activity (cf. Figure 7).
Figure 6. The ZnF and OBD domains bind to overlapping sites on DNA. Small angle X-ray scattering reveals the dynamic interactions of LigIII and deletion mutants in the 1:1 complex described in Figure 7A. (A) The normalized pair distribution function p(r) is consistent with an elongated conformation of LigIII in the presence or absence of a DNA duplex containing a three nucleotide overhang. (B) A normalized Kratky plot of the scattering data shows evidence of flexible residues in the presence or absence of DNA, which is modeled as a flexible ZnF domain in panel (C). (D) Deletion of the ZnF (ΔZnF LigIII) significantly narrows the p(r) distribution and reveals a large conformational transition upon binding to DNA. (E) The normalized Kratky plot of ΔZnF LigIII in complex with DNA shows a bell shaped Gaussian curve, indicative of a compact structure when bound to DNA. (F) The SAXS data are consistent with a model of ΔZnF LigIII encircling the DNA end as for the crystal structure of ΔZnF LigIII bound to nicked DNA (30). (G) Deletion of the C-terminal OBD domain (ΔOBD LigIII) narrows the pair distribution function p(r) of LigIII in a manner similar to deletion of the ZnF domain. This result suggests that the ZnF can engage DNA when the OBD is deleted, resulting in a compact conformation of ΔOBD LigIII bound to DNA. (H) A normalized Kratky plot of ΔOBD LigIII bound to DNA reveals a Gaussian curve consistent with a compact structure with the ZnF engaging the bound DNA as modeled in panel (I).
Figure 7. One molecule of LigIII binds two molecules of DNA in the bridging complex. (A) The DNA binding activity of LigIII was monitored by fluorescence anisotropy of a labeled DNA under conditions of stoichiometric binding. A 5′ FITC labeled duplex (800 nM) containing a three nucleotide overhang that cannot pair with itself was titrated with increasing concentrations of LigIII and the change in fluorescence anisotropy was measured. The DNA concentration in this assay is ∼5-fold higher than the apparent equilibrium binding constant (Kapp ∼ 154 nM) determined with limiting concentrations of DNA and LigIII in excess. The measured binding stoichiometry of 1:1 for the LigIII:DNA complex was additionally confirmed by repeating the titration experiment at a higher concentration of DNA (1600 nM; not shown). (B) A binding stoichiometry of 1:2 (ratio = 0.5) was measured for LigIII in complex with a 5′ FITC labeled, blunt-ended DNA duplex (800 nM) that can form the DNA bridging complex. The same binding stoichiometry was determined in a binding reaction containing a higher concentration of the DNA (1600 nM; not shown).
Figure 8. LigIII is stably bound to two DNAs in the bridging complex. (A) Streptavidin magnetic beads coated with a 5′ biotinylated DNA duplex were used to capture LigIII together with a 5′ FITC labeled DNA in a pull-down assay. The FITC labeled DNA on the beads was analyzed by urea PAGE and quantification of fluorescence emission intensity in the gel (see ‘Materials and Methods’ section). (B) Upper panel, denaturing urea PAGE analysis of the FITC labeled DNA recovered from the beads. Lower panel, quantitation of fluorescence intensity in the gel. Samples 4 and 5 are replicates containing LigIII in a bridging complex. Samples 9 and 10 are replicates containing the ΔZnF LigIII mutant protein, which does not form the bridging complex. Figure 8 shows the pull-down of DNAs with complementary 3 nt overhangs in complex with LigIII. Additional controls are shown in the legend above the gel. Supplementary Figure S3 shows the pull-down of a LigIII DNA bridging complex incorporating two blunt-ended DNAs.
Abdou,
DNA ligase III acts as a DNA strand break sensor in the cellular orchestration of DNA strand break repair.
2015, Pubmed,
Xenbase
Abdou,
DNA ligase III acts as a DNA strand break sensor in the cellular orchestration of DNA strand break repair.
2015,
Pubmed
,
Xenbase
Akbari,
Overexpression of DNA ligase III in mitochondria protects cells against oxidative stress and improves mitochondrial DNA base excision repair.
2014,
Pubmed
,
Xenbase
Alexeyev,
The maintenance of mitochondrial DNA integrity--critical analysis and update.
2013,
Pubmed
Bhagwat,
Delayed DNA joining at 3' mismatches by human DNA ligases.
1999,
Pubmed
,
Xenbase
Caldecott,
XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro.
1996,
Pubmed
,
Xenbase
Caldecott,
An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III.
1994,
Pubmed
,
Xenbase
Chen,
Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase.
2000,
Pubmed
Chen,
Development of a fluorescence resonance energy transfer assay for measuring the activity of Streptococcus pneumoniae DNA ligase, an enzyme essential for DNA replication, repair, and recombination.
2002,
Pubmed
Classen,
Implementation and performance of SIBYLS: a dual endstation small-angle X-ray scattering and macromolecular crystallography beamline at the Advanced Light Source.
2013,
Pubmed
Cotner-Gohara,
Two DNA-binding and nick recognition modules in human DNA ligase III.
2008,
Pubmed
,
Xenbase
Cotner-Gohara,
Human DNA ligase III recognizes DNA ends by dynamic switching between two DNA-bound states.
2010,
Pubmed
,
Xenbase
El-Khamisy,
A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage.
2003,
Pubmed
Ellenberger,
Eukaryotic DNA ligases: structural and functional insights.
2008,
Pubmed
GUINIER,
Correction of measurements of low-angle X-ray scattering.
1947,
Pubmed
Gao,
DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair.
2011,
Pubmed
,
Xenbase
Hayashi,
Influence of monovalent cations on the activity of T4 DNA ligase in the presence of polyethylene glycol.
1985,
Pubmed
Hura,
Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS).
2009,
Pubmed
Katyal,
Disconnecting XRCC1 and DNA ligase III.
2011,
Pubmed
,
Xenbase
Kulczyk,
Solution structure and DNA binding of the zinc-finger domain from DNA ligase IIIalpha.
2004,
Pubmed
König,
Synchrotron radiation solution X-ray scattering study of the pH dependence of the quaternary structure of yeast pyruvate decarboxylase.
1992,
Pubmed
Lakshmipathy,
Antisense-mediated decrease in DNA ligase III expression results in reduced mitochondrial DNA integrity.
2001,
Pubmed
,
Xenbase
Lakshmipathy,
Mitochondrial DNA ligase III function is independent of Xrcc1.
2000,
Pubmed
,
Xenbase
Langelier,
Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity.
2011,
Pubmed
Leppard,
Physical and functional interaction between DNA ligase IIIalpha and poly(ADP-Ribose) polymerase 1 in DNA single-strand break repair.
2003,
Pubmed
,
Xenbase
Liang,
Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks.
2008,
Pubmed
,
Xenbase
Liu,
DNA repair in mammalian mitochondria: Much more than we thought?
2010,
Pubmed
Mackey,
DNA ligase III is recruited to DNA strand breaks by a zinc finger motif homologous to that of poly(ADP-ribose) polymerase. Identification of two functionally distinct DNA binding regions within DNA ligase III.
1999,
Pubmed
,
Xenbase
Ochi,
Structure of the catalytic region of DNA ligase IV in complex with an Artemis fragment sheds light on double-strand break repair.
2013,
Pubmed
Oh,
DNA ligase III and DNA ligase IV carry out genetically distinct forms of end joining in human somatic cells.
2014,
Pubmed
,
Xenbase
Pascal,
A flexible interface between DNA ligase and PCNA supports conformational switching and efficient ligation of DNA.
2006,
Pubmed
Pascal,
Human DNA ligase I completely encircles and partially unwinds nicked DNA.
2004,
Pubmed
Rassool,
Targeting abnormal DNA double strand break repair in cancer.
2010,
Pubmed
Ruhanen,
Involvement of DNA ligase III and ribonuclease H1 in mitochondrial DNA replication in cultured human cells.
2011,
Pubmed
,
Xenbase
Sekiguchi,
Nick sensing by vaccinia virus DNA ligase requires a 5' phosphate at the nick and occupancy of the adenylate binding site on the enzyme.
1997,
Pubmed
Shokolenko,
Mitochondrial DNA ligase is dispensable for the viability of cultured cells but essential for mtDNA maintenance.
2013,
Pubmed
,
Xenbase
Simsek,
Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.
2011,
Pubmed
,
Xenbase
Simsek,
DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
2011,
Pubmed
,
Xenbase
Soni,
Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
2014,
Pubmed
,
Xenbase
Sriskanda,
Chlorella virus DNA ligase: nick recognition and mutational analysis.
1998,
Pubmed
Stankova,
Conformational transitions of proteins engaged in DNA double-strand break repair, analysed by tryptophan fluorescence emission and FRET.
2012,
Pubmed
Taylor,
Role of the DNA ligase III zinc finger in polynucleotide binding and ligation.
1998,
Pubmed
,
Xenbase
Taylor,
The DNA ligase III zinc finger stimulates binding to DNA secondary structure and promotes end joining.
2000,
Pubmed
,
Xenbase
Taylor,
Kinetic mechanism of human DNA ligase I reveals magnesium-dependent changes in the rate-limiting step that compromise ligation efficiency.
2011,
Pubmed
Tobin,
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
2013,
Pubmed
Tobin,
Targeting abnormal DNA repair in therapy-resistant breast cancers.
2012,
Pubmed
Tomkinson,
DNA ligases: structure, reaction mechanism, and function.
2006,
Pubmed
Tomkinson,
Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.
2013,
Pubmed
Wang,
DNA ligase III as a candidate component of backup pathways of nonhomologous end joining.
2005,
Pubmed